The Management Committee (MC) of the International Pharmaceutical Regulators Forum (IPRF) met in Geneva, Switzerland on November 12-13, 2017. Celia Lourenco (Chair, Health Canada), Bianca Zimon (Co

The Steering Committee (SC) of the International Generic Drug Regulators Programme (IGDRP) met in Brasilia, Brazil on November 1-2, 2017. The Chair, ANVISA and Co-Chair (Health Canada), together with

Members and Observers of the International Generic Drug Regulators Programme (IGDRP)participated in its 5th meeting which took place in Ottawa, Canada from June 5th-8th, 2017. Concurrent meetings

The Management Committee (MC) of the International Pharmaceutical Regulators Forum (IPRF) met in Montreal, Canada, May 28-29, 2017.   Joan Blair (Chair, US FDA), Bianca Zimon (Co-Chair,

The Members of the International Generic Drug Regulators Programme (IGDRP) participated in its 4th meeting held in Mexico, from 17 to 20 October 2016. The Members focused primarily on the future

The Management Committee (MC) of the International Pharmaceutical Regulators Forum (IPRF) met in Osaka, Japan, November 6-7, 2016. During this meeting, the MC endorsed elements for a long-term

The Management Committee of the International Pharmaceutical Regulators Forum (IPRF) met in Lisbon, Portugal, June 12-13,  2016. It continued a strategy development process that had been

The 3rd meeting of the International Generic Drug Regulators Programme (IGDRP) was held in Strasbourg, France, from 9-12 May 2016, the primary focus of the meeting being the resolution of barriers to

The Biowaivers Working Group held a face to face meeting on 2-3 November 2015 as part of the 2nd meeting of the International Generic Drug Regulators Programme (IGDRP) in Seoul, South Korea, with a

With a view to improving international cooperation and work-sharing in the assessment of ASMF/DMF for generic drugs, the members of the ASMF/DMF Working Group held a face to face meeting as part of